A Busy Week for Six Biotech Stocks

by Benzinga Staff

June 20, 2011 6:46 AM | 6 seconds read | Make a Comment

Acura, Pain Therapeutics and Fibrocell deal with FDA approval decisions while Curis presents new cancer drug data.

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!